RetinalGenix Technologies (RTGN) Other Operating Expenses (2020 - 2026)
RetinalGenix Technologies recorded quarterly Other Operating Expenses of $210016.0 in Q1 2026, down 25.33% quarter-over-quarter from $281246.0 in Q4 2025, and down 9.45% year-over-year from $231933.0 in Q1 2025.
RetinalGenix Technologies' Other Operating Expenses history runs 7 years deep, the most recent figure standing at $210016.0 for Q1 2026.
- In Q1 2026, Other Operating Expenses fell 9.45% year-over-year to $210016.0; the TTM figure through Mar 2026 stood at $1.0 million (down 8.14% YoY), while the FY2025 annual figure was $1.0 million, down 60.13% from the prior year.
- Other Operating Expenses came in at $210016.0 for Q1 2026 at RetinalGenix Technologies, down from $281246.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $2.1 million in Q3 2022 to a low of $55051.0 in Q1 2022.
- A 5-year average of $400987.8 and a median of $231933.0 in 2025 frame the typical range for Other Operating Expenses.
- Across the five-year window, Other Operating Expenses surged 3721.14% in 2022 and tumbled 86.62% in 2025, its largest moves.
- RetinalGenix Technologies' Other Operating Expenses stood at $78509.0 in 2022, then retreated by 0.0% to $78507.0 in 2023, then soared by 370.9% to $369687.0 in 2024, then slipped by 23.92% to $281246.0 in 2025, then decreased by 25.33% to $210016.0 in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $210016.0, $281246.0, and $277226.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RetinalGenix Technologies | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 210,016.00 |
| Dec 31, 2025 | 281,246.00 |
| Sep 30, 2025 | 277,226.00 |
| Jun 30, 2025 | 250,189.00 |
| Mar 31, 2025 | 231,933.00 |
| Dec 31, 2024 | 369,687.00 |
| Sep 30, 2024 | 296,256.00 |
| Jun 30, 2024 | 211,009.00 |
| Mar 31, 2024 | 1.73 Mn |
| Dec 31, 2023 | 78,507.00 |
| Sep 30, 2023 | 428,683.00 |
| Jun 30, 2023 | 78,509.00 |
| Mar 31, 2023 | 78,509.00 |
| Dec 31, 2022 | 78,509.00 |
| Sep 30, 2022 | 2.10 Mn |
| Jun 30, 2022 | 55,051.00 |
| Mar 31, 2022 | -297,029.00 |
| Dec 31, 2021 | 1.79 Mn |
| Sep 30, 2021 | 55,051.00 |
| Jun 30, 2021 | 86,329.00 |
| Mar 31, 2021 | 111,487.00 |
| Dec 31, 2020 | 403,833.00 |
| Sep 30, 2020 | 468,202.00 |